Sign In
Buy LLY
$1,231.58
+45.87 (+3.87%)
At Close: Aug 10, 2026
The Zacks Analyst Blog Highlights Eli Lilly, Thermo Fisher Scientific, TotalEnergies, Amgen and Marathon Petroleum
12:15pm, Monday, 18'th Jul 2022 Zacks Investment Research
Eli Lilly, Thermo Fisher Scientific, TotalEnergies, Amgen and Marathon Petroleum have been included in this Analyst Blog.
Eli Lilly (LLY) Gains But Lags Market: What You Should Know
09:45pm, Friday, 15'th Jul 2022 Zacks Investment Research
Eli Lilly (LLY) closed at $331.60 in the latest trading session, marking a +1.44% move from the prior day.
Top Stock Reports for Eli Lilly, Thermo Fisher & TotalEnergies
06:39pm, Friday, 15'th Jul 2022 Zacks Investment Research
Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), Thermo Fisher Scientific Inc. (TMO), and TotalEnergies SE (TTE).
This Stock Is Down By 13% This Year: Here's Why It's a Buy
12:05pm, Friday, 15'th Jul 2022 The Motley Fool
The market may be undervaluing this drugmaker.
Strength Seen in H Lundbeck AS (HLUYY): Can Its 11.2% Jump Turn into More Strength?
01:46pm, Wednesday, 13'th Jul 2022 Zacks Investment Research
H Lundbeck AS (HLUYY) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down
Should You Invest in the Invesco Dynamic Pharmaceuticals ETF (PJP)?
10:20am, Wednesday, 13'th Jul 2022 Zacks Investment Research
Sector ETF report for PJP
Eli Lilly (LLY) Gains As Market Dips: What You Should Know
09:50pm, Monday, 11'th Jul 2022 Zacks Investment Research
Eli Lilly (LLY) closed at $331.07 in the latest trading session, marking a +0.18% move from the prior day.
Incyte (INCY) Outperforms Industry YTD: What Lies Ahead?
03:16pm, Monday, 11'th Jul 2022 Zacks Investment Research
Incyte (INCY) outperforms the industry in the year so far as lead drug Jakafi maintains momentum. Pipeline progress has also been encouraging.
Beat The Bear With 3 Tools: Dividends, Dividends And Dividends
12:28pm, Sunday, 10'th Jul 2022 Investing.comEli Lilly: Powering Ahead, But Too Strong
12:04pm, Sunday, 10'th Jul 2022
Eli Lilly has seen very strong momentum on the operational front, but certainly in its shares as well. Expectations of new approvals have pushed up valuations a great deal, as the company has quite a
3 No-Brainer Stocks to Buy in July
10:08am, Saturday, 09'th Jul 2022 The Motley Fool
These stocks appear to be clear winners.
Growth stocks remain resilient in weakening economy, says Neuberger's Jason Tauber
05:13pm, Friday, 08'th Jul 2022
Jason Tauber, Neuberger Berman large cap disciplined growth and the disruptors portfolio manager, joins 'Closing Bell: Overtime' to discus his bullish case for the growth trade.
Radius (RDUS) Randomizes Patient in Prader-Willi Syndrome Study
03:40pm, Friday, 08'th Jul 2022 Zacks Investment Research
Radius (RDUS) randomizes the first patient in the SCOUT-015 study of pipeline candidate, RAD011, for Prader-Willi Syndrome.
Want $1 Million by Retirement? Here's How Much You Should Invest Today
01:08pm, Friday, 08'th Jul 2022 The Motley Fool
If you start early, you don't need to invest all that much to grow your portfolio to $1 million.
The direction of M&A in biotech is very, very vast, says Oppenheimer's Holz
03:24pm, Thursday, 07'th Jul 2022
Jared Holz, Oppenheimer healthcare equity strategist, joins 'Power Lunch' to discuss the possibility of M&A in the healthcare sector, if investors remain focused on the oncology side of healthcare bus
